AbPrazole Plus

AbPrazole Plus

AbPrazole Plus Omeprazole + Probiotic 210g bulk pack – equivalent to 50 x 4.2g single sachets, is for treatment and prevention of equine gastric ulcers in easy-to-measure, easy-to-feed, once a day dosages of flavorless, blue, enteric coated, granules containing Omeprazole plus a probiotic.

Omeprazole is from the family of proton pump inhibitors (PPI’s) that blocks secretion of acid and assists by reducing and neutralizing acid in the horse’s stomach allowing improved healing of existing ulcer damage.

The presence of a probiotic helps restore natural intestinal flora, leading to more rapid recovery and better nutrient absorption.AbPrazole Plus
V-Go can help control blood sugar over 24 hours with just 1 application and 1 insulin1.
V-Go uses 1 small needle that the patient never sees.
All mealtime insulin doses are delivered by the patient throughout the day with just a push of a button.
Patients who may not be appropriate for V-GoAbPrazole Plus
Patients who have to make regular adjustments or modifications to their basal rate during a 24-hour period, or whose amount of insulin used at meals requires adjustments of less than 2-Unit increments, should not use V-Go as it may result in hypoglycemia.
matrix-degrading enzymes.AbPrazole Plus
It has also been shown to stimulate epidermal stem cell differentiator. When applied
by subcutaneous injection, it assists in the generation of new blood vessels and aids
wound healing by promoting skin cell regeneration.
How does TB-1000 Work Scientifically?AbPrazole Plus
One of TB-1000 4’s key mechanisms of action is its ability to regulate the cell-building
protein, actin, a vital component of cell structure and movement. Of the thousands of
proteins present in cells, actin represents up to 10% of the total proteins which
therefore plays a major role in the genetic makeup of the cell.
This potent peptide is a member of the ubiquitous family of 16 related molecules with
a high conservation of sequence and localization in most tissues and circulating cells
in the body. TB-1000 not only binds to actin, but also blocks actin polymerization and
is the actin-sequestering molecule in Eukaryota cells.
TB-1000 was identified as a gene that was up-regulated four to six fold during early
blood vessel formation and found to promote the growth of new blood cells from the
existing vessels.
This peptide is present in wound fluid and when administered subcutaneously